nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—endogenous depression—Valproic Acid—epilepsy syndrome	0.325	1	CpDpCtD
Vilazodone—SLC6A4—epilepsy syndrome	0.115	0.587	CbGaD
Vilazodone—CYP2D6—epilepsy syndrome	0.0811	0.413	CbGaD
Vilazodone—CYP2C18—Clobazam—epilepsy syndrome	0.0542	0.173	CbGbCtD
Vilazodone—CYP2C18—Phenytoin—epilepsy syndrome	0.0403	0.128	CbGbCtD
Vilazodone—CYP2C18—Propofol—epilepsy syndrome	0.0376	0.12	CbGbCtD
Vilazodone—CYP2C18—Phenobarbital—epilepsy syndrome	0.0359	0.114	CbGbCtD
Vilazodone—CYP2C18—Diazepam—epilepsy syndrome	0.0341	0.109	CbGbCtD
Vilazodone—CYP2C18—Valproic Acid—epilepsy syndrome	0.0269	0.0855	CbGbCtD
Vilazodone—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00696	0.0222	CbGbCtD
Vilazodone—CYP3A4—Trimethadione—epilepsy syndrome	0.00647	0.0206	CbGbCtD
Vilazodone—CYP3A4—Felbamate—epilepsy syndrome	0.00647	0.0206	CbGbCtD
Vilazodone—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00608	0.0194	CbGbCtD
Vilazodone—CYP2D6—Propofol—epilepsy syndrome	0.00575	0.0183	CbGbCtD
Vilazodone—CYP3A4—Clonazepam—epilepsy syndrome	0.0055	0.0175	CbGbCtD
Vilazodone—CYP3A4—Clobazam—epilepsy syndrome	0.00527	0.0168	CbGbCtD
Vilazodone—CYP3A4—Rufinamide—epilepsy syndrome	0.00448	0.0143	CbGbCtD
Vilazodone—CYP3A4—Carbamazepine—epilepsy syndrome	0.00437	0.0139	CbGbCtD
Vilazodone—CYP3A4—Primidone—epilepsy syndrome	0.00408	0.013	CbGbCtD
Vilazodone—CYP3A4—Phenytoin—epilepsy syndrome	0.00392	0.0125	CbGbCtD
Vilazodone—CYP3A4—Propofol—epilepsy syndrome	0.00365	0.0116	CbGbCtD
Vilazodone—CYP3A4—Acetazolamide—epilepsy syndrome	0.00349	0.0111	CbGbCtD
Vilazodone—CYP3A4—Phenobarbital—epilepsy syndrome	0.00349	0.0111	CbGbCtD
Vilazodone—CYP3A4—Midazolam—epilepsy syndrome	0.00344	0.011	CbGbCtD
Vilazodone—CYP3A4—Diazepam—epilepsy syndrome	0.00331	0.0105	CbGbCtD
Vilazodone—CYP3A4—Zonisamide—epilepsy syndrome	0.00323	0.0103	CbGbCtD
Vilazodone—CYP3A4—Valproic Acid—epilepsy syndrome	0.00261	0.00831	CbGbCtD
Vilazodone—CYP3A4—Topiramate—epilepsy syndrome	0.00235	0.0075	CbGbCtD
Vilazodone—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00154	0.0869	CbGeAlD
Vilazodone—DRD2—telencephalic ventricle—epilepsy syndrome	0.00139	0.0785	CbGeAlD
Vilazodone—SLC6A4—ganglion—epilepsy syndrome	0.00108	0.0609	CbGeAlD
Vilazodone—HTR1A—ganglion—epilepsy syndrome	0.00096	0.0541	CbGeAlD
Vilazodone—DRD2—ganglion—epilepsy syndrome	0.000867	0.0489	CbGeAlD
Vilazodone—SLC6A4—hindbrain—epilepsy syndrome	0.00082	0.0462	CbGeAlD
Vilazodone—HTR1A—hindbrain—epilepsy syndrome	0.000728	0.041	CbGeAlD
Vilazodone—DRD2—hindbrain—epilepsy syndrome	0.000658	0.0371	CbGeAlD
Vilazodone—SLC6A4—brainstem—epilepsy syndrome	0.00047	0.0265	CbGeAlD
Vilazodone—SLC6A4—forebrain—epilepsy syndrome	0.000454	0.0256	CbGeAlD
Vilazodone—HTR1A—brainstem—epilepsy syndrome	0.000417	0.0235	CbGeAlD
Vilazodone—SLC6A4—telencephalon—epilepsy syndrome	0.000417	0.0235	CbGeAlD
Vilazodone—HTR1A—forebrain—epilepsy syndrome	0.000403	0.0227	CbGeAlD
Vilazodone—CYP2D6—hindbrain—epilepsy syndrome	0.000395	0.0223	CbGeAlD
Vilazodone—DRD2—brainstem—epilepsy syndrome	0.000377	0.0212	CbGeAlD
Vilazodone—HTR1A—telencephalon—epilepsy syndrome	0.00037	0.0209	CbGeAlD
Vilazodone—DRD2—forebrain—epilepsy syndrome	0.000364	0.0205	CbGeAlD
Vilazodone—DRD2—telencephalon—epilepsy syndrome	0.000335	0.0188	CbGeAlD
Vilazodone—SLC6A4—midbrain—epilepsy syndrome	0.000299	0.0169	CbGeAlD
Vilazodone—SLC6A4—spinal cord—epilepsy syndrome	0.000292	0.0165	CbGeAlD
Vilazodone—Aripiprazole—CHRM3—epilepsy syndrome	0.000282	0.13	CrCbGaD
Vilazodone—HTR1A—midbrain—epilepsy syndrome	0.000266	0.015	CbGeAlD
Vilazodone—Aripiprazole—CHRM1—epilepsy syndrome	0.000263	0.121	CrCbGaD
Vilazodone—SLC6A4—head—epilepsy syndrome	0.00026	0.0146	CbGeAlD
Vilazodone—HTR1A—spinal cord—epilepsy syndrome	0.000259	0.0146	CbGeAlD
Vilazodone—SLC6A4—nervous system—epilepsy syndrome	0.000246	0.0139	CbGeAlD
Vilazodone—DRD2—midbrain—epilepsy syndrome	0.00024	0.0135	CbGeAlD
Vilazodone—SLC6A4—central nervous system—epilepsy syndrome	0.000237	0.0134	CbGeAlD
Vilazodone—HTR1A—head—epilepsy syndrome	0.000231	0.013	CbGeAlD
Vilazodone—CYP2D6—brainstem—epilepsy syndrome	0.000227	0.0128	CbGeAlD
Vilazodone—CYP2D6—forebrain—epilepsy syndrome	0.000219	0.0123	CbGeAlD
Vilazodone—HTR1A—nervous system—epilepsy syndrome	0.000219	0.0123	CbGeAlD
Vilazodone—Aripiprazole—CHRM2—epilepsy syndrome	0.000215	0.099	CrCbGaD
Vilazodone—Aripiprazole—HTR7—epilepsy syndrome	0.000214	0.0985	CrCbGaD
Vilazodone—HTR1A—central nervous system—epilepsy syndrome	0.00021	0.0119	CbGeAlD
Vilazodone—DRD2—head—epilepsy syndrome	0.000208	0.0117	CbGeAlD
Vilazodone—HTR1A—cerebellum—epilepsy syndrome	0.000206	0.0116	CbGeAlD
Vilazodone—CYP2D6—telencephalon—epilepsy syndrome	0.000201	0.0113	CbGeAlD
Vilazodone—DRD2—nervous system—epilepsy syndrome	0.000198	0.0111	CbGeAlD
Vilazodone—DRD2—central nervous system—epilepsy syndrome	0.00019	0.0107	CbGeAlD
Vilazodone—SLC6A4—brain—epilepsy syndrome	0.000188	0.0106	CbGeAlD
Vilazodone—DRD2—cerebellum—epilepsy syndrome	0.000186	0.0105	CbGeAlD
Vilazodone—Aripiprazole—ADRA2A—epilepsy syndrome	0.000183	0.0845	CrCbGaD
Vilazodone—Trazodone—ADRA2A—epilepsy syndrome	0.000182	0.0841	CrCbGaD
Vilazodone—HTR1A—brain—epilepsy syndrome	0.000167	0.00941	CbGeAlD
Vilazodone—DRD2—brain—epilepsy syndrome	0.000151	0.00851	CbGeAlD
Vilazodone—Aripiprazole—SLC6A4—epilepsy syndrome	0.00014	0.0645	CrCbGaD
Vilazodone—Trazodone—SLC6A4—epilepsy syndrome	0.000139	0.0642	CrCbGaD
Vilazodone—CYP2D6—head—epilepsy syndrome	0.000125	0.00705	CbGeAlD
Vilazodone—CYP3A4—nervous system—epilepsy syndrome	0.000121	0.00679	CbGeAlD
Vilazodone—CYP2D6—nervous system—epilepsy syndrome	0.000119	0.00669	CbGeAlD
Vilazodone—CYP3A4—central nervous system—epilepsy syndrome	0.000116	0.00654	CbGeAlD
Vilazodone—CYP2D6—central nervous system—epilepsy syndrome	0.000114	0.00644	CbGeAlD
Vilazodone—CYP2D6—cerebellum—epilepsy syndrome	0.000112	0.00629	CbGeAlD
Vilazodone—Aripiprazole—HTR2A—epilepsy syndrome	0.000107	0.0495	CrCbGaD
Vilazodone—Trazodone—HTR2A—epilepsy syndrome	0.000107	0.0493	CrCbGaD
Vilazodone—Aripiprazole—CYP2D6—epilepsy syndrome	9.83e-05	0.0453	CrCbGaD
Vilazodone—Trazodone—CYP2D6—epilepsy syndrome	9.78e-05	0.0451	CrCbGaD
Vilazodone—CYP2D6—brain—epilepsy syndrome	9.07e-05	0.00511	CbGeAlD
Vilazodone—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	7.99e-05	0.000772	CcSEcCtD
Vilazodone—Nausea—Lacosamide—epilepsy syndrome	7.99e-05	0.000771	CcSEcCtD
Vilazodone—Insomnia—Clonazepam—epilepsy syndrome	7.98e-05	0.000771	CcSEcCtD
Vilazodone—Feeling abnormal—Diazepam—epilepsy syndrome	7.97e-05	0.000769	CcSEcCtD
Vilazodone—Decreased appetite—Zonisamide—epilepsy syndrome	7.96e-05	0.000769	CcSEcCtD
Vilazodone—Diarrhoea—Acetazolamide—epilepsy syndrome	7.96e-05	0.000769	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	7.95e-05	0.000767	CcSEcCtD
Vilazodone—Nervous system disorder—Lamotrigine—epilepsy syndrome	7.93e-05	0.000766	CcSEcCtD
Vilazodone—Insomnia—Phenytoin—epilepsy syndrome	7.93e-05	0.000766	CcSEcCtD
Vilazodone—Mental disorder—Valproic Acid—epilepsy syndrome	7.93e-05	0.000766	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	7.91e-05	0.000764	CcSEcCtD
Vilazodone—Fatigue—Zonisamide—epilepsy syndrome	7.9e-05	0.000763	CcSEcCtD
Vilazodone—Insomnia—Oxcarbazepine—epilepsy syndrome	7.89e-05	0.000762	CcSEcCtD
Vilazodone—Malnutrition—Valproic Acid—epilepsy syndrome	7.88e-05	0.000761	CcSEcCtD
Vilazodone—Paraesthesia—Phenytoin—epilepsy syndrome	7.87e-05	0.00076	CcSEcCtD
Vilazodone—Somnolence—Clonazepam—epilepsy syndrome	7.85e-05	0.000758	CcSEcCtD
Vilazodone—Hyperhidrosis—Lamotrigine—epilepsy syndrome	7.82e-05	0.000755	CcSEcCtD
Vilazodone—Somnolence—Phenytoin—epilepsy syndrome	7.8e-05	0.000753	CcSEcCtD
Vilazodone—Dyspepsia—Clonazepam—epilepsy syndrome	7.77e-05	0.00075	CcSEcCtD
Vilazodone—Flatulence—Valproic Acid—epilepsy syndrome	7.76e-05	0.00075	CcSEcCtD
Vilazodone—Somnolence—Oxcarbazepine—epilepsy syndrome	7.75e-05	0.000749	CcSEcCtD
Vilazodone—Nausea—Clobazam—epilepsy syndrome	7.75e-05	0.000749	CcSEcCtD
Vilazodone—Asthenia—Propofol—epilepsy syndrome	7.75e-05	0.000749	CcSEcCtD
Vilazodone—Dyspepsia—Phenytoin—epilepsy syndrome	7.72e-05	0.000745	CcSEcCtD
Vilazodone—Dysgeusia—Valproic Acid—epilepsy syndrome	7.71e-05	0.000745	CcSEcCtD
Vilazodone—Feeling abnormal—Felbamate—epilepsy syndrome	7.71e-05	0.000745	CcSEcCtD
Vilazodone—Dizziness—Acetazolamide—epilepsy syndrome	7.69e-05	0.000743	CcSEcCtD
Vilazodone—Dyspepsia—Oxcarbazepine—epilepsy syndrome	7.68e-05	0.000741	CcSEcCtD
Vilazodone—Decreased appetite—Clonazepam—epilepsy syndrome	7.67e-05	0.000741	CcSEcCtD
Vilazodone—Nervousness—Valproic Acid—epilepsy syndrome	7.65e-05	0.000739	CcSEcCtD
Vilazodone—Eye disorder—Pregabalin—epilepsy syndrome	7.64e-05	0.000738	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	7.63e-05	0.000736	CcSEcCtD
Vilazodone—Decreased appetite—Phenytoin—epilepsy syndrome	7.62e-05	0.000736	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	7.62e-05	0.000736	CcSEcCtD
Vilazodone—Fatigue—Clonazepam—epilepsy syndrome	7.61e-05	0.000735	CcSEcCtD
Vilazodone—Cardiac disorder—Pregabalin—epilepsy syndrome	7.59e-05	0.000733	CcSEcCtD
Vilazodone—Asthenia—Midazolam—epilepsy syndrome	7.58e-05	0.000732	CcSEcCtD
Vilazodone—Decreased appetite—Oxcarbazepine—epilepsy syndrome	7.58e-05	0.000732	CcSEcCtD
Vilazodone—Insomnia—Carbamazepine—epilepsy syndrome	7.57e-05	0.000731	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	7.57e-05	0.000731	CcSEcCtD
Vilazodone—Fatigue—Phenytoin—epilepsy syndrome	7.56e-05	0.00073	CcSEcCtD
Vilazodone—Feeling abnormal—Zonisamide—epilepsy syndrome	7.55e-05	0.000729	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	7.53e-05	0.000727	CcSEcCtD
Vilazodone—Fatigue—Oxcarbazepine—epilepsy syndrome	7.52e-05	0.000726	CcSEcCtD
Vilazodone—Paraesthesia—Carbamazepine—epilepsy syndrome	7.52e-05	0.000726	CcSEcCtD
Vilazodone—Asthenia—Levetiracetam—epilepsy syndrome	7.49e-05	0.000723	CcSEcCtD
Vilazodone—Hallucination—Gabapentin—epilepsy syndrome	7.46e-05	0.000721	CcSEcCtD
Vilazodone—Somnolence—Carbamazepine—epilepsy syndrome	7.44e-05	0.000719	CcSEcCtD
Vilazodone—Vision blurred—Valproic Acid—epilepsy syndrome	7.42e-05	0.000717	CcSEcCtD
Vilazodone—Vomiting—Acetazolamide—epilepsy syndrome	7.4e-05	0.000714	CcSEcCtD
Vilazodone—Diarrhoea—Propofol—epilepsy syndrome	7.39e-05	0.000714	CcSEcCtD
Vilazodone—Tremor—Valproic Acid—epilepsy syndrome	7.38e-05	0.000713	CcSEcCtD
Vilazodone—Connective tissue disorder—Gabapentin—epilepsy syndrome	7.37e-05	0.000712	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	7.37e-05	0.000712	CcSEcCtD
Vilazodone—Dyspepsia—Carbamazepine—epilepsy syndrome	7.37e-05	0.000712	CcSEcCtD
Vilazodone—Insomnia—Lamotrigine—epilepsy syndrome	7.32e-05	0.000707	CcSEcCtD
Vilazodone—Pollakiuria—Topiramate—epilepsy syndrome	7.28e-05	0.000703	CcSEcCtD
Vilazodone—Decreased appetite—Carbamazepine—epilepsy syndrome	7.28e-05	0.000703	CcSEcCtD
Vilazodone—Feeling abnormal—Clonazepam—epilepsy syndrome	7.27e-05	0.000703	CcSEcCtD
Vilazodone—Paraesthesia—Lamotrigine—epilepsy syndrome	7.26e-05	0.000701	CcSEcCtD
Vilazodone—Erectile dysfunction—Topiramate—epilepsy syndrome	7.26e-05	0.000701	CcSEcCtD
Vilazodone—Agitation—Valproic Acid—epilepsy syndrome	7.24e-05	0.000699	CcSEcCtD
Vilazodone—Asthenia—Fosphenytoin—epilepsy syndrome	7.23e-05	0.000698	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	7.23e-05	0.000698	CcSEcCtD
Vilazodone—Feeling abnormal—Phenytoin—epilepsy syndrome	7.23e-05	0.000698	CcSEcCtD
Vilazodone—Fatigue—Carbamazepine—epilepsy syndrome	7.22e-05	0.000697	CcSEcCtD
Vilazodone—Somnolence—Lamotrigine—epilepsy syndrome	7.19e-05	0.000695	CcSEcCtD
Vilazodone—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	7.19e-05	0.000694	CcSEcCtD
Vilazodone—Mental disorder—Pregabalin—epilepsy syndrome	7.17e-05	0.000692	CcSEcCtD
Vilazodone—Dizziness—Propofol—epilepsy syndrome	7.14e-05	0.00069	CcSEcCtD
Vilazodone—Diarrhoea—Levetiracetam—epilepsy syndrome	7.14e-05	0.00069	CcSEcCtD
Vilazodone—Dyspepsia—Lamotrigine—epilepsy syndrome	7.12e-05	0.000688	CcSEcCtD
Vilazodone—Malnutrition—Pregabalin—epilepsy syndrome	7.12e-05	0.000688	CcSEcCtD
Vilazodone—Asthenia—Vigabatrin—epilepsy syndrome	7.05e-05	0.00068	CcSEcCtD
Vilazodone—Decreased appetite—Lamotrigine—epilepsy syndrome	7.03e-05	0.000679	CcSEcCtD
Vilazodone—Aripiprazole—ABCB1—epilepsy syndrome	7.02e-05	0.0324	CrCbGaD
Vilazodone—Flatulence—Pregabalin—epilepsy syndrome	7.02e-05	0.000678	CcSEcCtD
Vilazodone—Eye disorder—Gabapentin—epilepsy syndrome	7.01e-05	0.000677	CcSEcCtD
Vilazodone—Dizziness—Midazolam—epilepsy syndrome	6.99e-05	0.000675	CcSEcCtD
Vilazodone—Trazodone—ABCB1—epilepsy syndrome	6.99e-05	0.0322	CrCbGaD
Vilazodone—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	6.98e-05	0.000674	CcSEcCtD
Vilazodone—Fatigue—Lamotrigine—epilepsy syndrome	6.97e-05	0.000674	CcSEcCtD
Vilazodone—Dysgeusia—Pregabalin—epilepsy syndrome	6.97e-05	0.000673	CcSEcCtD
Vilazodone—Cardiac disorder—Gabapentin—epilepsy syndrome	6.96e-05	0.000672	CcSEcCtD
Vilazodone—Palpitations—Valproic Acid—epilepsy syndrome	6.96e-05	0.000672	CcSEcCtD
Vilazodone—Asthenia—Diazepam—epilepsy syndrome	6.94e-05	0.00067	CcSEcCtD
Vilazodone—Nervousness—Pregabalin—epilepsy syndrome	6.92e-05	0.000668	CcSEcCtD
Vilazodone—Nausea—Acetazolamide—epilepsy syndrome	6.91e-05	0.000667	CcSEcCtD
Vilazodone—Dizziness—Levetiracetam—epilepsy syndrome	6.9e-05	0.000667	CcSEcCtD
Vilazodone—Feeling abnormal—Carbamazepine—epilepsy syndrome	6.9e-05	0.000666	CcSEcCtD
Vilazodone—Diarrhoea—Fosphenytoin—epilepsy syndrome	6.89e-05	0.000666	CcSEcCtD
Vilazodone—Vomiting—Propofol—epilepsy syndrome	6.87e-05	0.000663	CcSEcCtD
Vilazodone—Vomiting—Midazolam—epilepsy syndrome	6.72e-05	0.000649	CcSEcCtD
Vilazodone—Diarrhoea—Vigabatrin—epilepsy syndrome	6.72e-05	0.000649	CcSEcCtD
Vilazodone—Asthenia—Felbamate—epilepsy syndrome	6.71e-05	0.000648	CcSEcCtD
Vilazodone—Vision blurred—Pregabalin—epilepsy syndrome	6.71e-05	0.000648	CcSEcCtD
Vilazodone—Arthralgia—Valproic Acid—epilepsy syndrome	6.71e-05	0.000648	CcSEcCtD
Vilazodone—Tremor—Pregabalin—epilepsy syndrome	6.67e-05	0.000644	CcSEcCtD
Vilazodone—Feeling abnormal—Lamotrigine—epilepsy syndrome	6.67e-05	0.000644	CcSEcCtD
Vilazodone—Dizziness—Fosphenytoin—epilepsy syndrome	6.66e-05	0.000643	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	6.66e-05	0.000643	CcSEcCtD
Vilazodone—Vomiting—Levetiracetam—epilepsy syndrome	6.64e-05	0.000641	CcSEcCtD
Vilazodone—Diarrhoea—Diazepam—epilepsy syndrome	6.62e-05	0.000639	CcSEcCtD
Vilazodone—Asthenia—Zonisamide—epilepsy syndrome	6.57e-05	0.000635	CcSEcCtD
Vilazodone—Mental disorder—Gabapentin—epilepsy syndrome	6.57e-05	0.000635	CcSEcCtD
Vilazodone—Dry mouth—Valproic Acid—epilepsy syndrome	6.56e-05	0.000633	CcSEcCtD
Vilazodone—Agitation—Pregabalin—epilepsy syndrome	6.54e-05	0.000632	CcSEcCtD
Vilazodone—Malnutrition—Gabapentin—epilepsy syndrome	6.53e-05	0.000631	CcSEcCtD
Vilazodone—Dizziness—Vigabatrin—epilepsy syndrome	6.49e-05	0.000627	CcSEcCtD
Vilazodone—Flatulence—Gabapentin—epilepsy syndrome	6.43e-05	0.000621	CcSEcCtD
Vilazodone—Nausea—Propofol—epilepsy syndrome	6.42e-05	0.00062	CcSEcCtD
Vilazodone—Vomiting—Fosphenytoin—epilepsy syndrome	6.41e-05	0.000619	CcSEcCtD
Vilazodone—Diarrhoea—Felbamate—epilepsy syndrome	6.4e-05	0.000618	CcSEcCtD
Vilazodone—Dysgeusia—Gabapentin—epilepsy syndrome	6.39e-05	0.000617	CcSEcCtD
Vilazodone—Dizziness—Diazepam—epilepsy syndrome	6.39e-05	0.000617	CcSEcCtD
Vilazodone—Nervousness—Gabapentin—epilepsy syndrome	6.34e-05	0.000612	CcSEcCtD
Vilazodone—Asthenia—Clonazepam—epilepsy syndrome	6.33e-05	0.000612	CcSEcCtD
Vilazodone—Nervous system disorder—Valproic Acid—epilepsy syndrome	6.3e-05	0.000609	CcSEcCtD
Vilazodone—Palpitations—Pregabalin—epilepsy syndrome	6.29e-05	0.000608	CcSEcCtD
Vilazodone—Asthenia—Phenytoin—epilepsy syndrome	6.29e-05	0.000608	CcSEcCtD
Vilazodone—Nausea—Midazolam—epilepsy syndrome	6.28e-05	0.000606	CcSEcCtD
Vilazodone—Hallucination—Topiramate—epilepsy syndrome	6.28e-05	0.000606	CcSEcCtD
Vilazodone—Diarrhoea—Zonisamide—epilepsy syndrome	6.27e-05	0.000605	CcSEcCtD
Vilazodone—Asthenia—Oxcarbazepine—epilepsy syndrome	6.26e-05	0.000604	CcSEcCtD
Vilazodone—Vomiting—Vigabatrin—epilepsy syndrome	6.24e-05	0.000603	CcSEcCtD
Vilazodone—Skin disorder—Valproic Acid—epilepsy syndrome	6.24e-05	0.000603	CcSEcCtD
Vilazodone—Hyperhidrosis—Valproic Acid—epilepsy syndrome	6.21e-05	0.0006	CcSEcCtD
Vilazodone—Connective tissue disorder—Topiramate—epilepsy syndrome	6.2e-05	0.000599	CcSEcCtD
Vilazodone—Nausea—Levetiracetam—epilepsy syndrome	6.2e-05	0.000599	CcSEcCtD
Vilazodone—Dizziness—Felbamate—epilepsy syndrome	6.19e-05	0.000598	CcSEcCtD
Vilazodone—Convulsion—Pregabalin—epilepsy syndrome	6.17e-05	0.000596	CcSEcCtD
Vilazodone—Vision blurred—Gabapentin—epilepsy syndrome	6.15e-05	0.000594	CcSEcCtD
Vilazodone—Vomiting—Diazepam—epilepsy syndrome	6.15e-05	0.000594	CcSEcCtD
Vilazodone—Tremor—Gabapentin—epilepsy syndrome	6.12e-05	0.000591	CcSEcCtD
Vilazodone—Arthralgia—Pregabalin—epilepsy syndrome	6.06e-05	0.000585	CcSEcCtD
Vilazodone—Dizziness—Zonisamide—epilepsy syndrome	6.06e-05	0.000585	CcSEcCtD
Vilazodone—Diarrhoea—Clonazepam—epilepsy syndrome	6.04e-05	0.000583	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.02e-05	0.000581	CcSEcCtD
Vilazodone—Asthenia—Carbamazepine—epilepsy syndrome	6.01e-05	0.00058	CcSEcCtD
Vilazodone—Agitation—Gabapentin—epilepsy syndrome	6e-05	0.000579	CcSEcCtD
Vilazodone—Diarrhoea—Phenytoin—epilepsy syndrome	6e-05	0.000579	CcSEcCtD
Vilazodone—Nausea—Fosphenytoin—epilepsy syndrome	5.98e-05	0.000578	CcSEcCtD
Vilazodone—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.97e-05	0.000576	CcSEcCtD
Vilazodone—Vomiting—Felbamate—epilepsy syndrome	5.95e-05	0.000575	CcSEcCtD
Vilazodone—Dry mouth—Pregabalin—epilepsy syndrome	5.93e-05	0.000573	CcSEcCtD
Vilazodone—Eye disorder—Topiramate—epilepsy syndrome	5.9e-05	0.00057	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.86e-05	0.000566	CcSEcCtD
Vilazodone—Cardiac disorder—Topiramate—epilepsy syndrome	5.86e-05	0.000566	CcSEcCtD
Vilazodone—Dizziness—Clonazepam—epilepsy syndrome	5.84e-05	0.000564	CcSEcCtD
Vilazodone—Nausea—Vigabatrin—epilepsy syndrome	5.83e-05	0.000563	CcSEcCtD
Vilazodone—Vomiting—Zonisamide—epilepsy syndrome	5.82e-05	0.000562	CcSEcCtD
Vilazodone—Insomnia—Valproic Acid—epilepsy syndrome	5.81e-05	0.000561	CcSEcCtD
Vilazodone—Asthenia—Lamotrigine—epilepsy syndrome	5.8e-05	0.000561	CcSEcCtD
Vilazodone—Dizziness—Phenytoin—epilepsy syndrome	5.8e-05	0.00056	CcSEcCtD
Vilazodone—Paraesthesia—Valproic Acid—epilepsy syndrome	5.77e-05	0.000557	CcSEcCtD
Vilazodone—Palpitations—Gabapentin—epilepsy syndrome	5.77e-05	0.000557	CcSEcCtD
Vilazodone—Dizziness—Oxcarbazepine—epilepsy syndrome	5.77e-05	0.000557	CcSEcCtD
Vilazodone—Nausea—Diazepam—epilepsy syndrome	5.74e-05	0.000555	CcSEcCtD
Vilazodone—Diarrhoea—Carbamazepine—epilepsy syndrome	5.73e-05	0.000553	CcSEcCtD
Vilazodone—Somnolence—Valproic Acid—epilepsy syndrome	5.71e-05	0.000552	CcSEcCtD
Vilazodone—Nervous system disorder—Pregabalin—epilepsy syndrome	5.7e-05	0.00055	CcSEcCtD
Vilazodone—Dyspepsia—Valproic Acid—epilepsy syndrome	5.66e-05	0.000546	CcSEcCtD
Vilazodone—Convulsion—Gabapentin—epilepsy syndrome	5.66e-05	0.000546	CcSEcCtD
Vilazodone—Skin disorder—Pregabalin—epilepsy syndrome	5.64e-05	0.000545	CcSEcCtD
Vilazodone—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.62e-05	0.000543	CcSEcCtD
Vilazodone—Vomiting—Clonazepam—epilepsy syndrome	5.61e-05	0.000542	CcSEcCtD
Vilazodone—Decreased appetite—Valproic Acid—epilepsy syndrome	5.59e-05	0.00054	CcSEcCtD
Vilazodone—Vomiting—Phenytoin—epilepsy syndrome	5.58e-05	0.000538	CcSEcCtD
Vilazodone—Arthralgia—Gabapentin—epilepsy syndrome	5.56e-05	0.000537	CcSEcCtD
Vilazodone—Nausea—Felbamate—epilepsy syndrome	5.56e-05	0.000537	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.55e-05	0.000536	CcSEcCtD
Vilazodone—Vomiting—Oxcarbazepine—epilepsy syndrome	5.55e-05	0.000536	CcSEcCtD
Vilazodone—Fatigue—Valproic Acid—epilepsy syndrome	5.54e-05	0.000535	CcSEcCtD
Vilazodone—Dizziness—Carbamazepine—epilepsy syndrome	5.53e-05	0.000535	CcSEcCtD
Vilazodone—Diarrhoea—Lamotrigine—epilepsy syndrome	5.53e-05	0.000535	CcSEcCtD
Vilazodone—Mental disorder—Topiramate—epilepsy syndrome	5.53e-05	0.000534	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.52e-05	0.000533	CcSEcCtD
Vilazodone—Malnutrition—Topiramate—epilepsy syndrome	5.49e-05	0.00053	CcSEcCtD
Vilazodone—Nausea—Zonisamide—epilepsy syndrome	5.44e-05	0.000525	CcSEcCtD
Vilazodone—Dry mouth—Gabapentin—epilepsy syndrome	5.44e-05	0.000525	CcSEcCtD
Vilazodone—Flatulence—Topiramate—epilepsy syndrome	5.41e-05	0.000523	CcSEcCtD
Vilazodone—Dysgeusia—Topiramate—epilepsy syndrome	5.38e-05	0.00052	CcSEcCtD
Vilazodone—Dizziness—Lamotrigine—epilepsy syndrome	5.35e-05	0.000517	CcSEcCtD
Vilazodone—Nervousness—Topiramate—epilepsy syndrome	5.34e-05	0.000515	CcSEcCtD
Vilazodone—Vomiting—Carbamazepine—epilepsy syndrome	5.32e-05	0.000514	CcSEcCtD
Vilazodone—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.3e-05	0.000512	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.29e-05	0.000511	CcSEcCtD
Vilazodone—Insomnia—Pregabalin—epilepsy syndrome	5.26e-05	0.000508	CcSEcCtD
Vilazodone—Nausea—Clonazepam—epilepsy syndrome	5.24e-05	0.000506	CcSEcCtD
Vilazodone—Nervous system disorder—Gabapentin—epilepsy syndrome	5.23e-05	0.000505	CcSEcCtD
Vilazodone—Paraesthesia—Pregabalin—epilepsy syndrome	5.22e-05	0.000504	CcSEcCtD
Vilazodone—Nausea—Phenytoin—epilepsy syndrome	5.21e-05	0.000503	CcSEcCtD
Vilazodone—Nausea—Oxcarbazepine—epilepsy syndrome	5.18e-05	0.0005	CcSEcCtD
Vilazodone—Vision blurred—Topiramate—epilepsy syndrome	5.18e-05	0.0005	CcSEcCtD
Vilazodone—Skin disorder—Gabapentin—epilepsy syndrome	5.18e-05	0.0005	CcSEcCtD
Vilazodone—Somnolence—Pregabalin—epilepsy syndrome	5.17e-05	0.000499	CcSEcCtD
Vilazodone—Hyperhidrosis—Gabapentin—epilepsy syndrome	5.15e-05	0.000498	CcSEcCtD
Vilazodone—Tremor—Topiramate—epilepsy syndrome	5.15e-05	0.000497	CcSEcCtD
Vilazodone—Vomiting—Lamotrigine—epilepsy syndrome	5.14e-05	0.000497	CcSEcCtD
Vilazodone—Decreased appetite—Pregabalin—epilepsy syndrome	5.05e-05	0.000488	CcSEcCtD
Vilazodone—Agitation—Topiramate—epilepsy syndrome	5.05e-05	0.000488	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.02e-05	0.000485	CcSEcCtD
Vilazodone—Fatigue—Pregabalin—epilepsy syndrome	5.01e-05	0.000484	CcSEcCtD
Vilazodone—Nausea—Carbamazepine—epilepsy syndrome	4.97e-05	0.00048	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.85e-05	0.000469	CcSEcCtD
Vilazodone—Palpitations—Topiramate—epilepsy syndrome	4.85e-05	0.000469	CcSEcCtD
Vilazodone—Insomnia—Gabapentin—epilepsy syndrome	4.82e-05	0.000465	CcSEcCtD
Vilazodone—Nausea—Lamotrigine—epilepsy syndrome	4.8e-05	0.000464	CcSEcCtD
Vilazodone—Feeling abnormal—Pregabalin—epilepsy syndrome	4.79e-05	0.000462	CcSEcCtD
Vilazodone—Paraesthesia—Gabapentin—epilepsy syndrome	4.78e-05	0.000462	CcSEcCtD
Vilazodone—Convulsion—Topiramate—epilepsy syndrome	4.76e-05	0.00046	CcSEcCtD
Vilazodone—Somnolence—Gabapentin—epilepsy syndrome	4.74e-05	0.000458	CcSEcCtD
Vilazodone—Dyspepsia—Gabapentin—epilepsy syndrome	4.69e-05	0.000453	CcSEcCtD
Vilazodone—Arthralgia—Topiramate—epilepsy syndrome	4.68e-05	0.000452	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.64e-05	0.000449	CcSEcCtD
Vilazodone—Decreased appetite—Gabapentin—epilepsy syndrome	4.63e-05	0.000447	CcSEcCtD
Vilazodone—Asthenia—Valproic Acid—epilepsy syndrome	4.61e-05	0.000445	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.6e-05	0.000444	CcSEcCtD
Vilazodone—Fatigue—Gabapentin—epilepsy syndrome	4.59e-05	0.000444	CcSEcCtD
Vilazodone—Dry mouth—Topiramate—epilepsy syndrome	4.57e-05	0.000442	CcSEcCtD
Vilazodone—Diarrhoea—Valproic Acid—epilepsy syndrome	4.4e-05	0.000425	CcSEcCtD
Vilazodone—Nervous system disorder—Topiramate—epilepsy syndrome	4.4e-05	0.000425	CcSEcCtD
Vilazodone—Feeling abnormal—Gabapentin—epilepsy syndrome	4.39e-05	0.000424	CcSEcCtD
Vilazodone—Skin disorder—Topiramate—epilepsy syndrome	4.35e-05	0.000421	CcSEcCtD
Vilazodone—Hyperhidrosis—Topiramate—epilepsy syndrome	4.33e-05	0.000419	CcSEcCtD
Vilazodone—Dizziness—Valproic Acid—epilepsy syndrome	4.25e-05	0.000411	CcSEcCtD
Vilazodone—Asthenia—Pregabalin—epilepsy syndrome	4.17e-05	0.000403	CcSEcCtD
Vilazodone—Vomiting—Valproic Acid—epilepsy syndrome	4.09e-05	0.000395	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.08e-05	0.000394	CcSEcCtD
Vilazodone—Insomnia—Topiramate—epilepsy syndrome	4.05e-05	0.000392	CcSEcCtD
Vilazodone—Paraesthesia—Topiramate—epilepsy syndrome	4.03e-05	0.000389	CcSEcCtD
Vilazodone—Somnolence—Topiramate—epilepsy syndrome	3.99e-05	0.000385	CcSEcCtD
Vilazodone—Diarrhoea—Pregabalin—epilepsy syndrome	3.98e-05	0.000384	CcSEcCtD
Vilazodone—Dyspepsia—Topiramate—epilepsy syndrome	3.95e-05	0.000381	CcSEcCtD
Vilazodone—Decreased appetite—Topiramate—epilepsy syndrome	3.9e-05	0.000376	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.87e-05	0.000374	CcSEcCtD
Vilazodone—Fatigue—Topiramate—epilepsy syndrome	3.87e-05	0.000373	CcSEcCtD
Vilazodone—Dizziness—Pregabalin—epilepsy syndrome	3.84e-05	0.000371	CcSEcCtD
Vilazodone—Asthenia—Gabapentin—epilepsy syndrome	3.82e-05	0.000369	CcSEcCtD
Vilazodone—Nausea—Valproic Acid—epilepsy syndrome	3.82e-05	0.000369	CcSEcCtD
Vilazodone—Vomiting—Pregabalin—epilepsy syndrome	3.69e-05	0.000357	CcSEcCtD
Vilazodone—Feeling abnormal—Topiramate—epilepsy syndrome	3.69e-05	0.000357	CcSEcCtD
Vilazodone—Diarrhoea—Gabapentin—epilepsy syndrome	3.65e-05	0.000352	CcSEcCtD
Vilazodone—Dizziness—Gabapentin—epilepsy syndrome	3.52e-05	0.00034	CcSEcCtD
Vilazodone—Nausea—Pregabalin—epilepsy syndrome	3.45e-05	0.000333	CcSEcCtD
Vilazodone—Vomiting—Gabapentin—epilepsy syndrome	3.39e-05	0.000327	CcSEcCtD
Vilazodone—Asthenia—Topiramate—epilepsy syndrome	3.22e-05	0.000311	CcSEcCtD
Vilazodone—Nausea—Gabapentin—epilepsy syndrome	3.17e-05	0.000306	CcSEcCtD
Vilazodone—Diarrhoea—Topiramate—epilepsy syndrome	3.07e-05	0.000296	CcSEcCtD
Vilazodone—Dizziness—Topiramate—epilepsy syndrome	2.96e-05	0.000286	CcSEcCtD
Vilazodone—Vomiting—Topiramate—epilepsy syndrome	2.85e-05	0.000275	CcSEcCtD
Vilazodone—Nausea—Topiramate—epilepsy syndrome	2.66e-05	0.000257	CcSEcCtD
Vilazodone—HTR1A—Signaling Pathways—GABBR1—epilepsy syndrome	6.85e-06	0.000166	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—ABCB1—epilepsy syndrome	6.83e-06	0.000165	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HBEGF—epilepsy syndrome	6.74e-06	0.000163	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	6.69e-06	0.000162	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—AVP—epilepsy syndrome	6.66e-06	0.000161	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CDC42—epilepsy syndrome	6.65e-06	0.000161	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GAL—epilepsy syndrome	6.65e-06	0.000161	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GFAP—epilepsy syndrome	6.65e-06	0.000161	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—AKT3—epilepsy syndrome	6.62e-06	0.00016	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GAMT—epilepsy syndrome	6.6e-06	0.00016	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	6.6e-06	0.00016	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PNPO—epilepsy syndrome	6.6e-06	0.00016	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	6.6e-06	0.00016	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GRM5—epilepsy syndrome	6.57e-06	0.000159	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CHRM3—epilepsy syndrome	6.57e-06	0.000159	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CASP2—epilepsy syndrome	6.57e-06	0.000159	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HRH3—epilepsy syndrome	6.57e-06	0.000159	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	6.51e-06	0.000158	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—OPRM1—epilepsy syndrome	6.46e-06	0.000157	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—AVP—epilepsy syndrome	6.44e-06	0.000156	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GPX1—epilepsy syndrome	6.35e-06	0.000154	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NT5E—epilepsy syndrome	6.34e-06	0.000154	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ALAD—epilepsy syndrome	6.34e-06	0.000154	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CX3CR1—epilepsy syndrome	6.3e-06	0.000153	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—CCR5—epilepsy syndrome	6.23e-06	0.000151	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—BDKRB1—epilepsy syndrome	6.18e-06	0.00015	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CHRM2—epilepsy syndrome	6.18e-06	0.00015	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CX3CL1—epilepsy syndrome	6.18e-06	0.00015	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—QDPR—epilepsy syndrome	6.14e-06	0.000149	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CA4—epilepsy syndrome	6.14e-06	0.000149	CbGpPWpGaD
Vilazodone—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	6.12e-06	0.000148	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCR3—epilepsy syndrome	6.1e-06	0.000148	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—HTR2A—epilepsy syndrome	6.1e-06	0.000148	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	6.05e-06	0.000147	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	6.05e-06	0.000147	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CDC42—epilepsy syndrome	6.04e-06	0.000146	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GABBR1—epilepsy syndrome	6.01e-06	0.000146	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NPY—epilepsy syndrome	5.95e-06	0.000144	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ATP2A2—epilepsy syndrome	5.95e-06	0.000144	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	5.92e-06	0.000143	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—AVP—epilepsy syndrome	5.85e-06	0.000142	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ADSL—epilepsy syndrome	5.8e-06	0.000141	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—AGT—epilepsy syndrome	5.79e-06	0.00014	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—COX3—epilepsy syndrome	5.77e-06	0.00014	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HRH3—epilepsy syndrome	5.76e-06	0.00014	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HSPB1—epilepsy syndrome	5.74e-06	0.000139	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CRH—epilepsy syndrome	5.74e-06	0.000139	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—OXT—epilepsy syndrome	5.74e-06	0.000139	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CXCL2—epilepsy syndrome	5.74e-06	0.000139	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCL3—epilepsy syndrome	5.74e-06	0.000139	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GLUL—epilepsy syndrome	5.69e-06	0.000138	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—OPRM1—epilepsy syndrome	5.67e-06	0.000137	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CCR5—epilepsy syndrome	5.66e-06	0.000137	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	5.58e-06	0.000135	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—AGT—epilepsy syndrome	5.57e-06	0.000135	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—HTR2A—epilepsy syndrome	5.54e-06	0.000134	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CCR5—epilepsy syndrome	5.47e-06	0.000133	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	5.47e-06	0.000133	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	5.47e-06	0.000133	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	5.47e-06	0.000133	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PFKL—epilepsy syndrome	5.47e-06	0.000133	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	5.47e-06	0.000133	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—APOE—epilepsy syndrome	5.45e-06	0.000132	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCR3—epilepsy syndrome	5.36e-06	0.00013	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—HTR2A—epilepsy syndrome	5.36e-06	0.00013	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	5.35e-06	0.00013	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PTK2B—epilepsy syndrome	5.34e-06	0.000129	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TSC1—epilepsy syndrome	5.34e-06	0.000129	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—AGT—epilepsy syndrome	5.26e-06	0.000127	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	5.22e-06	0.000127	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NPY—epilepsy syndrome	5.22e-06	0.000126	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ATP2A2—epilepsy syndrome	5.22e-06	0.000126	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SST—epilepsy syndrome	5.19e-06	0.000126	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCR2—epilepsy syndrome	5.19e-06	0.000126	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NTRK2—epilepsy syndrome	5.19e-06	0.000126	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DUSP6—epilepsy syndrome	5.14e-06	0.000125	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—AGT—epilepsy syndrome	5.08e-06	0.000123	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADRA2A—epilepsy syndrome	5.08e-06	0.000123	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AQP1—epilepsy syndrome	5.07e-06	0.000123	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PLAT—epilepsy syndrome	5.06e-06	0.000123	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCL3—epilepsy syndrome	5.04e-06	0.000122	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CRH—epilepsy syndrome	5.04e-06	0.000122	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—OXT—epilepsy syndrome	5.04e-06	0.000122	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CXCL2—epilepsy syndrome	5.04e-06	0.000122	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HSPB1—epilepsy syndrome	5.04e-06	0.000122	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.01e-06	0.000121	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.01e-06	0.000121	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.01e-06	0.000121	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CCR5—epilepsy syndrome	4.97e-06	0.00012	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—BDKRB2—epilepsy syndrome	4.88e-06	0.000118	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CXCL12—epilepsy syndrome	4.88e-06	0.000118	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—POMC—epilepsy syndrome	4.87e-06	0.000118	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—HTR2A—epilepsy syndrome	4.86e-06	0.000118	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PRKCB—epilepsy syndrome	4.86e-06	0.000118	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL6ST—epilepsy syndrome	4.84e-06	0.000117	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	4.82e-06	0.000117	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—JUNB—epilepsy syndrome	4.79e-06	0.000116	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CNR1—epilepsy syndrome	4.79e-06	0.000116	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PLCB1—epilepsy syndrome	4.77e-06	0.000116	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.7e-06	0.000114	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—POMC—epilepsy syndrome	4.68e-06	0.000113	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TSC1—epilepsy syndrome	4.68e-06	0.000113	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PTK2B—epilepsy syndrome	4.68e-06	0.000113	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR7—epilepsy syndrome	4.67e-06	0.000113	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GBE1—epilepsy syndrome	4.65e-06	0.000113	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	4.65e-06	0.000113	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—AGT—epilepsy syndrome	4.62e-06	0.000112	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	4.59e-06	0.000111	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	4.59e-06	0.000111	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SST—epilepsy syndrome	4.56e-06	0.00011	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCR2—epilepsy syndrome	4.56e-06	0.00011	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NTRK2—epilepsy syndrome	4.56e-06	0.00011	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HBEGF—epilepsy syndrome	4.54e-06	0.00011	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—DUSP6—epilepsy syndrome	4.52e-06	0.000109	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADRA2A—epilepsy syndrome	4.46e-06	0.000108	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKT3—epilepsy syndrome	4.45e-06	0.000108	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PLAT—epilepsy syndrome	4.44e-06	0.000108	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—POMC—epilepsy syndrome	4.42e-06	0.000107	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.37e-06	0.000106	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ADAM10—epilepsy syndrome	4.35e-06	0.000105	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CCL2—epilepsy syndrome	4.33e-06	0.000105	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CXCL12—epilepsy syndrome	4.28e-06	0.000104	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—BDKRB2—epilepsy syndrome	4.28e-06	0.000104	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—POMC—epilepsy syndrome	4.28e-06	0.000104	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—ALB—epilepsy syndrome	4.27e-06	0.000103	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PRKCB—epilepsy syndrome	4.26e-06	0.000103	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.26e-06	0.000103	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL6ST—epilepsy syndrome	4.25e-06	0.000103	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CNR1—epilepsy syndrome	4.21e-06	0.000102	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—JUNB—epilepsy syndrome	4.21e-06	0.000102	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PLCB1—epilepsy syndrome	4.19e-06	0.000101	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.15e-06	0.0001	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.15e-06	0.0001	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—S100B—epilepsy syndrome	4.11e-06	9.96e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR7—epilepsy syndrome	4.1e-06	9.94e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SOCS3—epilepsy syndrome	4.07e-06	9.86e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CDC42—epilepsy syndrome	4.06e-06	9.84e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HBEGF—epilepsy syndrome	3.98e-06	9.65e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.96e-06	9.58e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.96e-06	9.58e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AVP—epilepsy syndrome	3.93e-06	9.53e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKT3—epilepsy syndrome	3.91e-06	9.47e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—POMC—epilepsy syndrome	3.88e-06	9.41e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.87e-06	9.38e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ADAM10—epilepsy syndrome	3.82e-06	9.25e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CCL2—epilepsy syndrome	3.8e-06	9.21e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.79e-06	9.19e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	3.74e-06	9.06e-05	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PTGS2—epilepsy syndrome	3.74e-06	9.05e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.72e-06	9.01e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	3.72e-06	9.01e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.65e-06	8.84e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.64e-06	8.82e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.62e-06	8.77e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	3.62e-06	8.76e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—S100B—epilepsy syndrome	3.61e-06	8.75e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	3.6e-06	8.73e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	3.6e-06	8.71e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SOCS3—epilepsy syndrome	3.58e-06	8.66e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CDC42—epilepsy syndrome	3.57e-06	8.64e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	3.48e-06	8.42e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AVP—epilepsy syndrome	3.45e-06	8.36e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	3.44e-06	8.33e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.42e-06	8.27e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	3.34e-06	8.1e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.32e-06	8.03e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	3.27e-06	7.93e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HES1—epilepsy syndrome	3.27e-06	7.91e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FYN—epilepsy syndrome	3.18e-06	7.69e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	3.16e-06	7.66e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	3.16e-06	7.65e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	3.11e-06	7.53e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	3.11e-06	7.53e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	3.11e-06	7.52e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—BCHE—epilepsy syndrome	3.1e-06	7.5e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	3.05e-06	7.39e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	3.04e-06	7.37e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NGF—epilepsy syndrome	3.02e-06	7.31e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3e-06	7.26e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3e-06	7.26e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	2.98e-06	7.22e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.96e-06	7.16e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	2.94e-06	7.11e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.92e-06	7.08e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—TH—epilepsy syndrome	2.91e-06	7.05e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	2.87e-06	6.96e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	2.87e-06	6.95e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	2.86e-06	6.92e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	2.73e-06	6.61e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AGT—epilepsy syndrome	2.73e-06	6.6e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APOE—epilepsy syndrome	2.67e-06	6.47e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KDR—epilepsy syndrome	2.62e-06	6.34e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	2.61e-06	6.33e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	2.56e-06	6.19e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	2.52e-06	6.1e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	2.51e-06	6.08e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.44e-06	5.92e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.43e-06	5.89e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.4e-06	5.81e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.38e-06	5.77e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.37e-06	5.73e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	2.33e-06	5.65e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	2.31e-06	5.6e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—POMC—epilepsy syndrome	2.29e-06	5.56e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	2.25e-06	5.44e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GPX1—epilepsy syndrome	2.17e-06	5.25e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	2.15e-06	5.2e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.14e-06	5.17e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	2.1e-06	5.1e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.03e-06	4.93e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	2.03e-06	4.92e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.03e-06	4.91e-05	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.95e-06	4.73e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	1.94e-06	4.69e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.93e-06	4.68e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.91e-06	4.63e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—TH—epilepsy syndrome	1.9e-06	4.61e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.9e-06	4.61e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RELA—epilepsy syndrome	1.88e-06	4.56e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	1.88e-06	4.55e-05	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—AKT1—epilepsy syndrome	1.88e-06	4.55e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.86e-06	4.51e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	1.85e-06	4.47e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	1.83e-06	4.43e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.77e-06	4.3e-05	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.71e-06	4.15e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	1.7e-06	4.12e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	1.69e-06	4.08e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—JUN—epilepsy syndrome	1.65e-06	4e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.64e-06	3.98e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	1.61e-06	3.89e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.6e-06	3.88e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.59e-06	3.85e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.57e-06	3.8e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	1.56e-06	3.77e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.53e-06	3.69e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SRC—epilepsy syndrome	1.48e-06	3.59e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.46e-06	3.54e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	1.44e-06	3.49e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.42e-06	3.44e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.28e-06	3.09e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.24e-06	3.01e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.22e-06	2.95e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	1.05e-06	2.54e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.05e-06	2.54e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ALB—epilepsy syndrome	9.54e-07	2.31e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	9.2e-07	2.23e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	8.35e-07	2.02e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AKT1—epilepsy syndrome	6.42e-07	1.55e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.2e-07	1.02e-05	CbGpPWpGaD
